Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BELIMUMAB
- Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis
- Belimumab for Treatment of cGVHD Following Allo-HCT
- Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
- Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus
- Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders
- Belimumab in Patients With Chronic Lymphocytic Leukemia
- The BeLimumab Antiphospholipid Syndrome Trial (BLAST)
- Belimumab In Treatment of Early Systemic Lupus Erythematosus
- Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)
- A Model About the Response of Belimumab in SLE
- Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
- Belimumab Treatment for IgG4-related Disease
- Multicenter Randomized Double-blind Study Comparing the Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated
- A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2
- Sequential Belimumab and T-cell Based Therapy in SLE
- Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects
- Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
- Belimumab With Rituximab for Primary Membranous Nephropathy
- Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
- Synergetic B-cell Immunomodulation in SLE - 2nd Study.
- CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
- A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE
- Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies
- Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
- Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia
- Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus
- Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
- Belimumab Impacting Transplant Eligibility
- Belimumab in Idiopathic Inflammatory Myositis
- Synergetic B-cell Immodulation in SLE
- Rituximab and Belimumab for Lupus Nephritis
- Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients
- Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76
- A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects
- A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
- Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
- Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
- Belimumab in Remission of VASculitis
- Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy
- Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
- Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
- A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
- BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
- A Study of Belimumab in the Prevention of Kidney Transplant Rejection
- Belimumab (BENLYSTA®) Pregnancy Registry
- Japanese phase1 Study of Belimumab (IV vs SC)
- A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
- A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
- GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia
- Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
- A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia
- Desensitization With Belimumab in Sensitized Patients Awaiting Kidney Transplant
- Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome
- Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99
- Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)
- A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057
- A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01
- A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
- A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
- A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)
- Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
Clinical trials list
click for details